FDA approves first oral treatment for postpartum depression
The Food and Drug Administration Friday approved a new hormone-based medication to treat postpartum depression, a condition that affects about 1 in 8 new mothers.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
More News: Depression | Food and Drug Administration (FDA) | Health | Hormones | Postnatal Depression